NEW YORK (GenomeWeb) – Quest Diagnostics today reported 2 percent year-over-year growth in its second quarter revenues, while its diagnostic information services revenues increased 3 percent.

For the three months ended June 30, overall revenues rose to $1.94 billion from $1.91 billion, matching the average analysts' estimate. Diagnostic information services grew to $1.86 billion from $1.81 billion from Q2 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.